- Home
- A-Z Publications
- CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders)
- Previous Issues
- Volume 9, Issue 5, 2010
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) - Volume 9, Issue 5, 2010
Volume 9, Issue 5, 2010
-
-
Commentary
By Sandra AmorVitamin D Links Genetic and Environmental Risk Factors in Multiple Sclerosis The risk to develop multiple sclerosis (MS) is well known to be co-defined by genetic and environmental factors. Possession of the major histocompatibility complex (MHC) allele HLA-DRB1*1501 represents by far the strongest genetic risk factor, while much smaller contributions are made by a range of other genes. Still, even this HLA-DRB1*1501 Read More
-
-
-
Editorial [Hot topic: New Frontiers in G Protein-Coupled Receptor Regulation of Neurological Disorders (Guest Editor: Stuart Maudsley)]
More LessHeptahelical G protein-coupled receptors (GPCR) constitute one of the most studied groups of proteins in the genome. Intense investigation of this protein superfamily is more than justified as therapeutics targeting the GPCR superfamily account for nearly half of the current pharmacopeia. Along with many years of exemplary scientific research into the activity of GPCRs has come the creeping concept of diminishing novel s Read More
-
-
-
Dopamine D1 Receptors, Regulation of Gene Expression in the Brain, and Neurodegeneration
Dopamine (DA), the most abundant catecholamine in the basal ganglia, participates in the regulation of motor functions and of cognitive processes such as learning and memory. Abnormalities in dopaminergic systems are thought to be the bases for some neuropsychiatric disorders including addiction, Parkinson's disease, and Schizophrenia. DA exerts its arrays of functions via stimulation of D1-like (D1 and D5) and D2-like (D2 Read More
-
-
-
Trafficking and Signaling of G Protein-Coupled Receptors in the Nervous System: Implications for Disease and Therapy
Authors: Nigel W. Bunnett and Graeme S. CottrellG protein-coupled receptors (GPCRs) are expressed throughout the nervous system where they regulate multiple physiological processes, participate in neurological diseases, and are major targets for therapy. Given that many GPCRs respond to neurotransmitters and hormones that are present in the extracellular fluid and which do not readily cross the plasma membrane, receptor trafficking to and from the plasma Read More
-
-
-
Ghrelin Receptor Signaling: A Promising Therapeutic Target for Metabolic Syndrome and Cognitive Dysfunction
Authors: Wei-na Cong, Erin Golden, Nick Pantaleo, Caitlin M. White, Stuart Maudsley and Bronwen MartinThe neuroendocrine hormone ghrelin is an octanoylated 28-residue peptide that exerts numerous physiological functions. Ghrelin exerts its effects on the body mainly through a highly conserved G protein-coupled receptor known as the growth hormone secretagagogue receptor subtype 1a (GHS-R1a). Ghrelin and GSH-R1a are widely expressed in both peripheral and central tissues/organs, and ghrelin signaling plays a critical Read More
-
-
-
Cannabinoid Receptors and Endocannabinoids: Role in Neuroinflammatory and Neurodegenerative Disorders
Authors: Tiziana Bisogno and Vincenzo Di MarzoThe G-protein coupled receptors for Δ9-tetrahydrocannabinol, the major psychoactive principle of marijuana, are known as cannabinoid receptors of type 1 (CB1) and 2 (CB2) and play important functions in degenerative and inflammatory disorders of the central nervous system. Whilst CB1 receptors are mostly expressed in neurons, where they regulate neurotransmitter release and synaptic strength, CB2 receptors are fou Read More
-
-
-
Group I Metabotropic Glutamate Receptor Signalling and its Implication in Neurological Disease
Authors: Fabiola M. Ribeiro, Maryse Paquet, Sean P. Cregan and Stephen S. G. FergusonStimulation of Group I metabotropic glutamate receptors (mGluR1 and mGluR5) leads to activation of a wide variety of signalling pathways. mGluRs couple to Gαq/11 proteins, activating phospholipase Cβ1 resulting in both diacylglycerol and inositol-1,4,5- triphosphate formation followed by the activation of protein kinase C. In addition, mGluR activation can lead to modulation of a number of ion channels, such as different types Read More
-
-
-
Prime Time for G-Protein-Coupled Receptor Heteromers as Therapeutic Targets for CNS disorders: The Dopamine D1-D3 Receptor Heteromer
Authors: Sergi Ferre, Carmen Lluis, Jose Luis Lanciego and Rafael FrancoA number of G-protein-coupled receptors (GPCRs) are currently under consideration as potential therapeutic targets for drugs acting in the central nervous system (CNS). Attempts to discover new medications have operated under the assumption that GPCRs are monomers and that a specific drug activates one single receptor coupled to one single signal transduction mechanism. In the neuronal membrane, GPCRs are now kn Read More
-
-
-
Regulation of Corticostriatal Synaptic Plasticity by G Protein-Coupled Receptors
Authors: Rakel Lopez de Maturana and Rosario Sanchez-PernauteDopamine modulation of excitatory neurotransmission is critical in the control of movement, emotion and reward. In the striatum, medium size spiny neurons (MSNs) are responsible for the integration of cortical and thalamic information that flows through parallel, partly overlapping, loops and determines adequate experience-dependent responses. Dopamine acts on MSNs through two sets of G protein-coupled receptors ( Read More
-
-
-
Opioid Regulation of Mu Receptor Internalisation: Relevance to the Development of Tolerance and Dependence
Authors: Juan F. Lopez-Gimenez and Graeme MilliganInternalisation of the mu opioid receptor from the surface of cells is generally achieved by receptor occupancy with agonist ligands of high efficacy. However, in many situations the potent analgesic morphine fails to promote internalisation effectively and whether there is a direct link between this and the propensity for the sustained use of morphine to result in both tolerance and dependence has been studied intensely. Althou Read More
-
-
-
The Mammalian Tachykinin Ligand-Receptor System: An Emerging Target for Central Neurological Disorders
Authors: Nick Pantaleo, Wayne Chadwick, Sung-Soo Park, Liyun Wang, Yu Zhou, Bronwen Martin and Stuart MaudsleyOur understanding of the complex signaling neurophysiology of the central nervous system has facilitated the exploration of potential novel receptor-ligand system targets for disorders of this most complex organ. In recent years, many relatively neglected receptor-ligand systems have been re-evaluated with respect to their ability to potently modulate discrete tracts in the central nervous system. One such system is th Read More
-
-
-
Heteromerization of G Protein-Coupled Receptors: Relevance to Neurological Disorders and Neurotherapeutics
Authors: Laura Albizu, Jose L. Moreno, Javier Gonzalez-Maeso and Stuart C. SealfonBecause G protein-coupled receptors (GPCRs) are numerous, widely expressed and involved in major physiological responses, they represent a relevant therapeutic target for drug discovery, particularly regarding pharmacological treatments of neurological disorders. Among the biological phenomena regulating receptor function, GPCR heteromerization is an important emerging area of interest and investigation. There is i Read More
-
-
-
Gonadotropin-Releasing Hormone Receptor System: Modulatory Role in Aging and Neurodegeneration
Authors: Liyun Wang, Wayne Chadwick, Sung-Soo Park, Yu Zhou, Nathan Silver, Bronwen Martin and Stuart MaudsleyReceptors for hormones of the hypothalamic-pituitary-gonadal axis are expressed throughout the brain. Age-related decline in gonadal reproductive hormones cause imbalances of this axis and many hormones in this axis have been functionally linked to neurodegenerative pathophysiology. Gonadotropin-releasing hormone (GnRH) plays a vital role in both central and peripheral reproductive regulation. GnRH Read More
-
-
-
Therapeutic Potential of Vasoactive Intestinal Peptide and its Receptors in Neurological Disorders
Authors: Caitlin M. White, Sunggoan Ji, Huan Cai, Stuart Maudsley and Bronwen MartinVasoactive intestinal peptide (VIP) is a basic 28 amino acid peptide that binds to a member of the class II family of G proteincoupled receptors (GPCRs). It is widely expressed throughout the body and plays an important role in numerous biological functions. VIP acts via three different GPCRs: VPAC1, VPAC2, and PAC1, which have been identified in various tissues, including brain, lung, kidney, gastrointestinal tract, tongu Read More
-
Volumes & issues
-
Volume 24 (2025)
-
Volume 23 (2024)
-
Volume 22 (2023)
-
Volume 21 (2022)
-
Volume 20 (2021)
-
Volume 19 (2020)
-
Volume 18 (2019)
-
Volume 17 (2018)
-
Volume 16 (2017)
-
Volume 15 (2016)
-
Volume 14 (2015)
-
Volume 13 (2014)
-
Volume 12 (2013)
-
Volume 11 (2012)
-
Volume 10 (2011)
-
Volume 9 (2010)
-
Volume 8 (2009)
-
Volume 7 (2008)
-
Volume 6 (2007)
-
Volume 5 (2006)
Most Read This Month
Article
content/journals/cnsnddt
Journal
10
5
false
en

Most Cited Most Cited RSS feed
-
-
A Retrospective, Multi-Center Cohort Study Evaluating the Severity- Related Effects of Cerebrolysin Treatment on Clinical Outcomes in Traumatic Brain Injury
Authors: Dafin F. Muresanu, Alexandru V. Ciurea, Radu M. Gorgan, Eva Gheorghita, Stefan I. Florian, Horatiu Stan, Alin Blaga, Nicolai Ianovici, Stefan M. Iencean, Dana Turliuc, Horia B. Davidescu, Cornel Mihalache, Felix M. Brehar, Anca . S. Mihaescu, Dinu C. Mardare, Aurelian Anghelescu, Carmen Chiparus, Magdalena Lapadat, Viorel Pruna, Dumitru Mohan, Constantin Costea, Daniel Costea, Claudiu Palade, Narcisa Bucur, Jesus Figueroa and Anton Alvarez
-
-
-
- More Less